$0.00
The series revealed that senior Food and Drug Administration officials dismissed explicit warnings of danger while racing to approve the diabetes pill Rezulin. It also disclosed that the government's top diabetes researcher was a paid consultant for the manufacturer of Rezulin while overseeing the drug's inclusion in a $150 million federal study. The reporting forced the FDA to acknowledge that at least 33 deaths were linked to Rezulin.
Looks like you haven't made a choice yet.
